EPISODE · May 17, 2026 · 15 MIN
Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026
from DX Today | No-Hype Podcast & News About AI & DX
Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026 Demis Hassabis's DeepMind spinout just closed a $2.1 billion Series B led by Thrive Capital with new participation from Temasek, CapitalG, the UK Sovereign AI Fund, and Abu Dhabi's MGX. Rick and Laura unpack what the IsoDDE engine, the Novartis, Eli Lilly, and Johnson & Johnson partnerships, and a Phase one trial target by year end mean for the future of pharma. The conversation also weighs the geopolitical signal of three sovereign wealth funds backing a single biotech in the same round. Hosted by Rick Spair and Laura. The DX Today Podcast brings you daily deep dives into the most consequential stories in the AI ecosystem. Send us fan mail: https://dxtoday.com/contact #AI #AIDrugDiscovery #IsomorphicLabs #DeepMind #BiotechAI
Embed this episode
What this episode covers
Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026 Demis Hassabis's DeepMind spinout just closed a $2.1 billion Series B led by Thrive Capital with new participation from Temasek, CapitalG, the UK Sovereign AI Fund, and Abu Dhabi's MGX. Rick and Laura unpack what the IsoDDE engine, the Novartis, Eli Lilly, and Johnson & Johnson partnerships, and a Phase one trial target by year end mean for...
NOW PLAYING
Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.